Compound Detail
CHEMBL111375
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL111375 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MDXZTEULLCCAPZ-UHFFFAOYSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
532.2
MW (Da)
5.80
ALogP
6
HBA
0
HBD
71.1
PSA (Ų)
0.32
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.1
IC50 1 meas. best 4.75
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| CCRF-CEM | EC50 | = | 8000.0 | nM | 5.1 | The compound was evaluated for prevention of the cytopathic effect of HIV-1 for ... | 8759644 |
| CCRF-CEM | IC50 | = | 18000.0 | nM | 4.75 | The compound was tested for cytotoxicity in CEM-SS cells for mock-infected CEM c... | 8759644 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 8759644 | 10.1021/jm960082v | CCRF-CEM | 2 |
| 8759644 | 10.1021/jm960082v | ADMET | 1 |
Data from ChEMBL 36 via Core Engine